Number of the records: 1
Preclinical Evaluation of (177)Lu-Nimotuzumab: A Potential Tool for Radioimmunotherapy of Epidermal Growth Factor Receptor-Overexpressing Tumors
- 1.Beckford, D. R., Eigner, S., Beran, M., Eigner-Henke, K., Lázníček, M., Melichar, F., Chinol, M. Preclinical Evaluation of (177)Lu-Nimotuzumab: A Potential Tool for Radioimmunotherapy of Epidermal Growth Factor Receptor-Overexpressing Tumors. Cancer Biotherapy and Radiopharmaceuticals. 2011, 26(3), 287-297. ISSN 1084-9785. E-ISSN 1557-8852. Available: doi: 10.1089/cbr.2010.0916
Number of the records: 1